The role of real-world data in advancement of Alzheimer’s treatments
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
Healthcare claims data are one of the most powerful sources of data in generating real-world...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million...
Closed claims no longer reflect real-world GLP-1 treatment patterns GLP-1 utilization continues to...
The therapeutic market that you know is shaped by the healthcare data that you can see. But when critical medical, specialty, clinical or longitudinal signals are absent from that view, the picture (and the decisions based on it) is less clear.